• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于全球印象的结构化访谈指南:提高 CNS 试验的可靠性和评分准确性。

A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials.

机构信息

Clintara LLC, 505 Tremont Street, Boston, MA, 02116, USA.

出版信息

Ann Gen Psychiatry. 2013 Jan 31;12(1):2. doi: 10.1186/1744-859X-12-2.

DOI:10.1186/1744-859X-12-2
PMID:23369692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3564924/
Abstract

BACKGROUND

The clinical global impression of severity (CGI-S) scale is a frequently used rating instrument for the assessment of global severity of illness in Central Nervous System (CNS) trials. Although scoring guidelines have been proposed to anchor these scores, the collection of sufficient documentation to support the derived score is not part of any standardized interview procedure. It is self evident that the absence of a standardized, documentary format can affect inter-rater reliability and may adversely affect the accuracy of the resulting data.

METHOD

We developed a structured interview guide for global impressions (SIGGI) and evaluated the instrument in a 2-visit study of ambulatory patients with Major Depressive Disorder (MDD) or schizophrenia. Blinded, site-independent raters listened to audio recorded SIGGI interviews administered by site-based CGI raters. We compared SIGGI-derived CGI-S scores between the two separate site-based raters and the site-independent raters.

RESULTS

We found significant intraclass correlations (p = 0.001) on all SIGGI-derived CGI-S scores between two separate site-based CGI raters with each other (r = 0.768) and with a blinded, site-independent rater (r = 0.748 and r = 0.706 respectively) and significant Pearson's correlations between CGI-S scores with all MADRS validity comparisons for MDD and PANSS comparisons for schizophrenia (p- 0.001 in all cases). Compared to site-based raters, the site-independent raters gave identical "dual" CGI-S scores to 67.6% and 68.2% of subjects at visit 1 and 77.1% at visit 2.

CONCLUSION

We suggest that the SIGGI may improve the inter-rater reliability and scoring precision of the CGI-S and have broad applicability in CNS clinical trials.

摘要

背景

临床总体印象严重程度量表(CGI-S)是中枢神经系统(CNS)试验中评估整体疾病严重程度的常用评分工具。尽管已经提出了评分指南来确定这些评分,但收集足够的文件来支持得出的评分并不是任何标准化访谈程序的一部分。不言而喻,缺乏标准化的文件格式会影响评分者间的可靠性,并可能对得出的数据的准确性产生不利影响。

方法

我们开发了一种用于总体印象的结构化访谈指南(SIGGI),并在一项门诊重度抑郁症(MDD)或精神分裂症患者的 2 访研究中评估了该工具。盲法、独立于地点的评分者收听由现场 CGI 评分者进行的音频记录的 SIGGI 访谈。我们比较了两个独立现场评分者与独立评分者之间的 SIGGI 衍生 CGI-S 评分。

结果

我们发现,两个独立现场 CGI 评分者之间的所有 SIGGI 衍生 CGI-S 评分(r = 0.768)以及与盲法、独立地点评分者(r = 0.748 和 r = 0.706)之间均存在显著的组内相关性(p = 0.001),并且在所有情况下,MDD 的 CGI-S 评分与 MADRS 所有有效性比较以及精神分裂症的 PANSS 比较之间均存在显著的 Pearson 相关性(p < 0.001)。与现场评分者相比,独立评分者在第 1 访和第 2 访中分别有 67.6%和 68.2%的受试者和 77.1%的受试者给出了相同的“双重”CGI-S 评分。

结论

我们建议,SIGGI 可能会提高 CGI-S 的评分者间可靠性和评分精度,并在 CNS 临床试验中具有广泛的适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df99/3564924/adafa91517d5/1744-859X-12-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df99/3564924/d0eeb2de2af8/1744-859X-12-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df99/3564924/adafa91517d5/1744-859X-12-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df99/3564924/d0eeb2de2af8/1744-859X-12-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df99/3564924/adafa91517d5/1744-859X-12-2-2.jpg

相似文献

1
A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials.用于全球印象的结构化访谈指南:提高 CNS 试验的可靠性和评分准确性。
Ann Gen Psychiatry. 2013 Jan 31;12(1):2. doi: 10.1186/1744-859X-12-2.
2
Impact of BPRS interview length on ratings reliability in a schizophrenia trial.在一项精神分裂症试验中,简明精神病评定量表(BPRS)访谈时长对评分可靠性的影响。
Eur Neuropsychopharmacol. 2015 Mar;25(3):312-8. doi: 10.1016/j.euroneuro.2014.11.023. Epub 2014 Dec 13.
3
Audio-digital recordings used for independent confirmation of site-based MADRS interview scores.用于独立确认基于现场的 MADRS 访谈评分的音频数字记录。
Eur Neuropsychopharmacol. 2014 Nov;24(11):1760-6. doi: 10.1016/j.euroneuro.2014.08.016. Epub 2014 Sep 6.
4
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.精神分裂症急性症状患者中临床医生评定的个人和社会表现量表的信度、效度及检测变化的能力。
Curr Med Res Opin. 2009 Feb;25(2):325-38. doi: 10.1185/03007990802611919.
5
Development of a clinical global impression scale for fatigue.疲劳临床整体印象量表的研制。
J Psychiatr Res. 2012 Mar;46(3):370-4. doi: 10.1016/j.jpsychires.2011.12.001. Epub 2012 Jan 10.
6
Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition.精神分裂症认知的临床总体印象(CGI-CogS):一种认知共同主要测量方法的信度和效度
Schizophr Res. 2008 Nov;106(1):59-69. doi: 10.1016/j.schres.2007.07.025. Epub 2007 Sep 27.
7
Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia.用于评估精神分裂症临床试验中评分可靠性的音频数字化记录。
Schizophr Res. 2021 Jun;232:54-60. doi: 10.1016/j.schres.2021.05.004. Epub 2021 May 17.
8
Audio-digital recordings for surveillance in clinical trials of major depressive disorder.用于重度抑郁症临床试验监测的音频数字记录。
Contemp Clin Trials Commun. 2019 Jan 8;14:100317. doi: 10.1016/j.conctc.2019.100317. eCollection 2019 Jun.
9
Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features).在一项有亚阈值轻躁狂(混合特征)的重性抑郁障碍研究中进行的评定监测和可靠性研究。
Int J Methods Psychiatr Res. 2018 Dec;27(4):e1729. doi: 10.1002/mpr.1729. Epub 2018 Jun 26.
10
Targeted scoring criteria reduce variance in global impressions.有针对性的评分标准可降低整体印象的差异。
Hum Psychopharmacol. 2008 Oct;23(7):629-33. doi: 10.1002/hup.966.

引用本文的文献

1
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression.对症状、功能及生活质量作为难治性抑郁症联合临床结局领域的研究。
J Mood Anxiety Disord. 2025 Apr 14;10:100121. doi: 10.1016/j.xjmad.2025.100121. eCollection 2025 Jun.
2
Impact of COVID-19 pandemic on physical and mental health status and care of adults with epilepsy in Germany.新冠疫情对德国成年癫痫患者身心健康状况及护理的影响。
Neurol Res Pract. 2022 Sep 22;4(1):44. doi: 10.1186/s42466-022-00209-5.
3
Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder.

本文引用的文献

1
Application of external review for subject selection in a schizophrenia trial.外部评审在一项精神分裂症试验受试者选择中的应用。
J Clin Psychopharmacol. 2012 Apr;32(2):825-6. doi: 10.1097/JCP.0b013e318248da90.
2
Development of a clinical global impression scale for fatigue.疲劳临床整体印象量表的研制。
J Psychiatr Res. 2012 Mar;46(3):370-4. doi: 10.1016/j.jpsychires.2011.12.001. Epub 2012 Jan 10.
3
Concordance between measures of functioning, symptoms, and change: examining the GAF, CGI-S, CGI-C, and PANSS.
用于广泛性焦虑症临床评估独立确认的音频记录
Innov Clin Neurosci. 2018 Apr 1;15(3-4):37-42.
4
Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings.常规临床环境中的跨诊断临床整体印象评分
Behav Sci (Basel). 2017 Jun 27;7(3):40. doi: 10.3390/bs7030040.
5
Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials.用维拉唑酮治疗的重度抑郁症患者疾病严重程度的分类改善:四项随机、安慰剂对照试验的事后分析
Neuropsychiatr Dis Treat. 2016 Dec 2;12:3073-3081. doi: 10.2147/NDT.S117581. eCollection 2016.
6
Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study.玛伐格卢兰特治疗脆性X综合征青少年:一项双盲治疗研究及后续开放标签长期扩展研究的临床总体印象改善源数据分析
J Neurodev Disord. 2016;8:1. doi: 10.1186/s11689-015-9134-5. Epub 2015 Dec 15.
7
Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone.精神病患者的药物依从性:一项针对患者改用长效注射用利培酮之前的观察性调查。
Patient Prefer Adherence. 2015 Sep 16;9:1333-41. doi: 10.2147/PPA.S89748. eCollection 2015.
8
Clinical Global Impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders.临床总体印象-严重程度评分作为精神分裂症和分裂情感性障碍缓解期常规评估的可靠指标。
Ann Gen Psychiatry. 2015 Feb 13;14:6. doi: 10.1186/s12991-015-0042-6. eCollection 2015.
9
Current findings from research on structured abstracts: an update.结构化摘要的当前研究发现:最新进展
J Med Libr Assoc. 2014 Jul;102(3):146-8. doi: 10.3163/1536-5050.102.3.002.
J Clin Psychopharmacol. 2010 Aug;30(4):478-80. doi: 10.1097/JCP.0b013e3181e7145f.
4
The clinical global impressions scale: applying a research tool in clinical practice.临床总体印象量表:在临床实践中应用一种研究工具。
Psychiatry (Edgmont). 2007 Jul;4(7):28-37.
5
Targeted scoring criteria reduce variance in global impressions.有针对性的评分标准可降低整体印象的差异。
Hum Psychopharmacol. 2008 Oct;23(7):629-33. doi: 10.1002/hup.966.
6
Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA).蒙哥马利-艾斯伯格抑郁评定量表结构化访谈指南(SIGMA)的编制与信度
Br J Psychiatry. 2008 Jan;192(1):52-8. doi: 10.1192/bjp.bp.106.032532.
7
Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.症状严重程度测量与变化之间的外推:对阳性和阴性症状量表(PANSS)及临床总体印象量表(CGI)的检验。
Schizophr Res. 2008 Jan;98(1-3):318-22. doi: 10.1016/j.schres.2007.09.006. Epub 2007 Oct 18.
8
The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia.临床总体印象-精神分裂症量表:一种用于测量精神分裂症所呈现症状多样性的简易工具。
Acta Psychiatr Scand Suppl. 2003(416):16-23. doi: 10.1034/j.1600-0447.107.s416.5.x.
9
Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.精神病理学评估的评分者间信度对临床试验效能及样本量计算的影响
J Clin Psychopharmacol. 2002 Jun;22(3):318-25. doi: 10.1097/00004714-200206000-00013.
10
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.《迷你国际神经精神病学访谈量表(M.I.N.I.)》:一种针对《精神疾病诊断与统计手册》第四版(DSM-IV)和《国际疾病分类》第十版(ICD-10)的结构化诊断性精神科访谈量表的开发与验证
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57.